Inventor · disambiguated record
Sunil Kumar Panigrahi
Also filed as: PANIGRAHI SUNIL KUMAR
25 granted patents·13 pending applications·66 citations·filing 2011–2024
94Inventor score
Files withASANA BIOSCIENCES LLC10MITOBRIDGE INC9AURIGENE DISCOVERY TECH LTD6AURIGENE ONCOLOGY LTD3ENDO PHARMACEUTICALS INC2
Top patents by PatentIndex Score
38 records- 0194US10399958B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2016·Granted Sep 3, 2019·7 cites·20 claims
- 0291US10479775B1PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2019·Granted Nov 19, 2019·7 cites·20 claims
- 0388US9062075B2Tetrahydropyridine derivatives as FabI inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2014·Granted Jun 23, 2015·8 cites·19 claims
- 0487US11578052B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2021·Granted Feb 14, 2023·1 cites·16 claims
- 0586US9382277B2Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2014·Granted Jul 5, 2016·8 cites·28 claims
- 0684US10906885B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2019·Granted Feb 2, 2021·1 cites·18 claims
- 0784US2024417383A1Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2024·Application pending·0 cites
- 0882US8729079B2Pyrimido-pyridazinone compounds and methods of use thereofVENKATESAN ARANAPAKAM·Filed 2012·Granted May 20, 2014·8 cites·25 claims
- 0982US2023373948A1Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2023·Application pending·0 cites
- 1081US9062002B2Substituted pyridine derivatives as FabI inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2012·Granted Jun 23, 2015·8 cites·19 claims
- 1181US8440662B2Substituted quinazoline and pyrido-pyrimidine derivativesSMITH ROGER ASTBURY·Filed 2011·Granted May 14, 2013·9 cites·46 claims
- 1280US10647720B2Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2018·Granted May 12, 2020·1 cites·33 claims
- 1380US9499495B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2014·Granted Nov 22, 2016·4 cites·43 claims
- 1475US9227969B2Compounds and compositions as inhibitors of MEKBOCK MARK GARY·Filed 2014·Granted Jan 5, 2016·2 cites·16 claims
- 1574US10968172B2USP30 inhibitorsMITOBRIDGE INC·Filed 2018·Granted Apr 6, 2021·1 cites·20 claims
- 1672US10183944B2Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2016·Granted Jan 22, 2019·1 cites·26 claims
- 1772US2021113578A1Quinazolines and azaquinazolines as dual inhibitors of ras/raf/mek/erk and pi3k/akt/pten/mtor pathwaysASANA BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 1870US10912779B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2019·Granted Feb 9, 2021·0 cites·23 claims
- 1969US2025122194A1Novel small molecule inhibitors of tead transcription factorsMASSACHUSETTS GEN HOSPITAL·Filed 2024·Application pending·0 cites
- 2066US2020190095A1Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 2159US9115092B2Substituted quinazoline and pyrido-pyrimidine derivativesASANA BIOSCIENCES LLC·Filed 2014·Granted Aug 25, 2015·0 cites·12 claims
- 2258US10226468B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2017·Granted Mar 12, 2019·0 cites·35 claims
- 2358US9757382B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2016·Granted Sep 12, 2017·0 cites·25 claims
- 2458US2025092066A1Substituted bicyclic heterocycles as malt-1 inhibitorsAURIGENE ONCOLOGY LTD·Filed 2023·Application pending·0 cites
- 2558US2022324878A1Imidazolidin-2-one compounds as prmt5 modulatorsAURIGENE DISCOVERY TECH LTD·Filed 2022·Application pending·0 cites
- 2657US2014073782A1Substituted Quinazoline and Pyrido-Pyrimidine DerivativesENDO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2756US2013190492A1Substituted quinazoline and pyrido-pyrimidine derivativesENDO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2855US12187722B2Small molecule inhibitors of TEAD transcription factorsMASSACHUSETTS GEN HOSPITAL·Filed 2020·Granted Jan 7, 2025·0 cites·23 claims
- 2955US2024132475A1Substituted pyrazolyl compounds as malt-1 inhibitorsAURIGENE ONCOLOGY LTD·Filed 2022·Application pending·0 cites
- 3055US2023414605A1Method of Treating Cancer Using FABP5 InhibitorsAURIGENE ONCOLOGY LTD·Filed 2021·Application pending·0 cites
- 3152US10011599B2Compounds and compositions as inhibitors of MEKNOVARTIS AG·Filed 2017·Granted Jul 3, 2018·0 cites·5 claims
- 3250US2023027075A1Sulfonamide compounds targeting cd73 and adenosine receptorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Application pending·0 cites
- 3348US9629836B2Compounds and compositions as inhibitors of MEKNOVARTIS AG·Filed 2015·Granted Apr 25, 2017·0 cites·5 claims
- 3444US11365205B2Imidazolidin-2-one compounds as PRMT5 modulatorsAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Jun 21, 2022·0 cites·16 claims
- 3541US11542275B2Substituted imidazolidin-2-one derivatives as PRMT5 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Jan 3, 2023·0 cites·19 claims
- 3641US11028054B21, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitorsMERCK PATENT GMBH·Filed 2018·Granted Jun 8, 2021·0 cites·156 claims
- 3740US10188627B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2015·Granted Jan 29, 2019·0 cites·28 claims
- 3835US2017305894A1Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →